• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症监护病房中进行个体化肾脏替代治疗起始:基于强化学习的策略,并在 AKIKI 随机对照试验上进行了外部验证。

Personalizing renal replacement therapy initiation in the intensive care unit: a reinforcement learning-based strategy with external validation on the AKIKI randomized controlled trials.

机构信息

Université Paris Cité and Université Sorbonne Paris Nord, INSERM, INRAE, Center for Research in Epidemiology and StatisticS (CRESS), Paris, F-75004, France.

Centre d'Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, Paris, F-75004, France.

出版信息

J Am Med Inform Assoc. 2024 Apr 19;31(5):1074-1083. doi: 10.1093/jamia/ocae004.

DOI:10.1093/jamia/ocae004
PMID:38452293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11031229/
Abstract

OBJECTIVE

The timely initiation of renal replacement therapy (RRT) for acute kidney injury (AKI) requires sequential decision-making tailored to individuals' evolving characteristics. To learn and validate optimal strategies for RRT initiation, we used reinforcement learning on clinical data from routine care and randomized controlled trials.

MATERIALS AND METHODS

We used the MIMIC-III database for development and AKIKI trials for validation. Participants were adult ICU patients with severe AKI receiving mechanical ventilation or catecholamine infusion. We used a doubly robust estimator to learn when to start RRT after the occurrence of severe AKI for three days in a row. We developed a "crude strategy" maximizing the population-level hospital-free days at day 60 (HFD60) and a "stringent strategy" recommending RRT when there is significant evidence of benefit for an individual. For validation, we evaluated the causal effects of implementing our learned strategies versus following current best practices on HFD60.

RESULTS

We included 3748 patients in the development set and 1068 in the validation set. Through external validation, the crude and stringent strategies yielded an average difference of 13.7 [95% CI -5.3 to 35.7] and 14.9 [95% CI -3.2 to 39.2] HFD60, respectively, compared to current best practices. The stringent strategy led to initiating RRT within 3 days in 14% of patients versus 38% under best practices.

DISCUSSION

Implementing our strategies could improve the average number of days that ICU patients spend alive and outside the hospital while sparing RRT for many.

CONCLUSION

We developed and validated a practical and interpretable dynamic decision support system for RRT initiation in the ICU.

摘要

目的

急性肾损伤(AKI)的肾脏替代治疗(RRT)的及时启动需要根据个体不断变化的特征进行序贯决策。为了学习和验证 RRT 启动的最佳策略,我们在常规护理和随机对照试验的临床数据上使用了强化学习。

材料与方法

我们使用 MIMIC-III 数据库进行开发,并在 AKIKI 试验中进行验证。参与者为接受机械通气或儿茶酚胺输注的重症 AKI 成年 ICU 患者。我们使用双重稳健估计器来学习在连续三天发生严重 AKI 后何时开始 RRT。我们制定了一种“粗略策略”,该策略将第 60 天(HFD60)时的无住院天数最大化,另一种“严格策略”建议在对个体有明显获益的情况下进行 RRT。为了验证,我们评估了实施我们学习到的策略与遵循当前最佳实践对 HFD60 的因果效应。

结果

我们在开发集中纳入了 3748 例患者,在验证集中纳入了 1068 例患者。通过外部验证,粗略策略和严格策略分别使 HFD60 的平均差异为 13.7 [95%CI-5.3 至 35.7]和 14.9 [95%CI-3.2 至 39.2],与当前最佳实践相比。与最佳实践相比,严格策略导致 14%的患者在 3 天内开始接受 RRT,而不是 38%。

讨论

实施我们的策略可以提高 ICU 患者活着且不在医院的天数的平均值,同时为许多患者节省 RRT。

结论

我们开发并验证了一种实用且可解释的 ICU 中 RRT 启动的动态决策支持系统。

相似文献

1
Personalizing renal replacement therapy initiation in the intensive care unit: a reinforcement learning-based strategy with external validation on the AKIKI randomized controlled trials.在重症监护病房中进行个体化肾脏替代治疗起始:基于强化学习的策略,并在 AKIKI 随机对照试验上进行了外部验证。
J Am Med Inform Assoc. 2024 Apr 19;31(5):1074-1083. doi: 10.1093/jamia/ocae004.
2
Comparison of two strategies for initiating renal replacement therapy in the intensive care unit: study protocol for a randomized controlled trial (AKIKI).重症监护病房中启动肾脏替代治疗的两种策略比较:一项随机对照试验(AKIKI)的研究方案
Trials. 2015 Apr 17;16:170. doi: 10.1186/s13063-015-0718-x.
3
Timing of renal replacement therapy initiation for acute kidney injury.急性肾损伤开始肾脏替代治疗的时机。
Cochrane Database Syst Rev. 2018 Dec 18;12(12):CD010612. doi: 10.1002/14651858.CD010612.pub2.
4
Early strategy vs. late initiation of renal replacement therapy in adult patients with acute kidney injury: an updated systematic review and meta-analysis of randomized controlled trials.早期策略与晚期开始肾脏替代治疗成人急性肾损伤患者:更新的系统评价和随机对照试验的荟萃分析。
Eur Rev Med Pharmacol Sci. 2023 Jul;27(13):6046-6057. doi: 10.26355/eurrev_202307_32959.
5
Timing of renal-replacement therapy in intensive care unit-related acute kidney injury.重症监护病房相关性急性肾损伤的肾脏替代治疗时机。
Curr Opin Crit Care. 2021 Dec 1;27(6):573-581. doi: 10.1097/MCC.0000000000000891.
6
The Artificial Kidney Initiation in Kidney Injury 2 (AKIKI2): study protocol for a randomized controlled trial.急性肾损伤中的人工肾启动2(AKIKI2):一项随机对照试验的研究方案
Trials. 2019 Dec 16;20(1):726. doi: 10.1186/s13063-019-3774-9.
7
Effect of Early vs Delayed Initiation of Renal Replacement Therapy on Mortality in Critically Ill Patients With Acute Kidney Injury: The ELAIN Randomized Clinical Trial.早期与延迟启动肾脏替代治疗对急性肾损伤危重症患者死亡率的影响:ELAIN 随机临床试验。
JAMA. 2016;315(20):2190-9. doi: 10.1001/jama.2016.5828.
8
[The timing of renal replacement therapy on mortality in patients with acute renal injury: a reanalysis of two recently published randomized control trials].[急性肾损伤患者肾脏替代治疗时机对死亡率的影响:两项近期发表的随机对照试验的重新分析]
Zhonghua Nei Ke Za Zhi. 2018 May 1;57(5):355-357. doi: 10.3760/cma.j.issn.0578-1426.2018.05.010.
9
Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.连续性肾脏替代治疗与间歇性血液透析作为严重急性肾损伤肾脏替代治疗的一线治疗方法比较:AKIKI 和 IDEAL-ICU 研究的二次分析。
Crit Care. 2022 Apr 4;26(1):93. doi: 10.1186/s13054-022-03955-9.
10
Early versus late initiation of renal replacement therapy in patients with acute kidney injury-a systematic review & meta-analysis of randomized controlled trials.急性肾损伤患者早期与晚期开始肾脏替代治疗——一项随机对照试验的系统评价与荟萃分析
BMC Nephrol. 2017 Feb 28;18(1):78. doi: 10.1186/s12882-017-0486-9.

引用本文的文献

1
Reinforcement Learning and Its Clinical Applications Within Healthcare: A Systematic Review of Precision Medicine and Dynamic Treatment Regimes.强化学习及其在医疗保健领域的临床应用:精准医学与动态治疗方案的系统综述
Healthcare (Basel). 2025 Jul 19;13(14):1752. doi: 10.3390/healthcare13141752.
2
A practical guide for nephrologist peer reviewers: evaluating artificial intelligence and machine learning research in nephrology.肾病学家同行评审员实用指南:评估肾脏病学中的人工智能和机器学习研究。
Ren Fail. 2025 Dec;47(1):2513002. doi: 10.1080/0886022X.2025.2513002. Epub 2025 Jul 7.
3
Systematic Exploration of Hospital Cost Variability: A Conformal Prediction-Based Outlier Detection Method for Electronic Health Records.医院成本变异性的系统探索:一种基于共形预测的电子健康记录异常值检测方法
AMIA Jt Summits Transl Sci Proc. 2025 Jun 10;2025:187-195. eCollection 2025.
4
Reinforcement Learning in Personalized Medicine: A Comprehensive Review of Treatment Optimization Strategies.个性化医疗中的强化学习:治疗优化策略的全面综述
Cureus. 2025 Apr 21;17(4):e82756. doi: 10.7759/cureus.82756. eCollection 2025 Apr.
5
When to stop immunotherapy for advanced melanoma: the emulated target trials.晚期黑色素瘤何时停止免疫治疗:模拟目标试验
EClinicalMedicine. 2024 Dec 4;78:102960. doi: 10.1016/j.eclinm.2024.102960. eCollection 2024 Dec.

本文引用的文献

1
Timing of dialysis in acute kidney injury using routinely collected data and dynamic treatment regimes.使用常规收集的数据和动态治疗方案来确定急性肾损伤的透析时机。
Crit Care. 2022 Nov 28;26(1):365. doi: 10.1186/s13054-022-04252-1.
2
Computer clinical decision support that automates personalized clinical care: a challenging but needed healthcare delivery strategy.计算机临床决策支持系统,实现个性化临床护理的自动化:一种具有挑战性但必要的医疗保健提供策略。
J Am Med Inform Assoc. 2022 Dec 13;30(1):178-194. doi: 10.1093/jamia/ocac143.
3
Optimizing the dynamic treatment regime of in-hospital warfarin anticoagulation in patients after surgical valve replacement using reinforcement learning.利用强化学习优化心脏瓣膜置换术后住院患者华法林抗凝的动态治疗方案。
J Am Med Inform Assoc. 2022 Sep 12;29(10):1722-1732. doi: 10.1093/jamia/ocac088.
4
Personalization of renal replacement therapy initiation: a secondary analysis of the AKIKI and IDEAL-ICU trials.个体化肾脏替代治疗起始时机:AKIKI 和 IDEAL-ICU 试验的二次分析。
Crit Care. 2022 Mar 21;26(1):64. doi: 10.1186/s13054-022-03936-y.
5
Extracorporeal Kidney-Replacement Therapy for Acute Kidney Injury.急性肾损伤的体外肾脏替代治疗
N Engl J Med. 2022 Mar 10;386(10):964-975. doi: 10.1056/NEJMra2104090.
6
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.拯救脓毒症运动:2021年脓毒症和脓毒性休克国际管理指南
Crit Care Med. 2021 Nov 1;49(11):e1063-e1143. doi: 10.1097/CCM.0000000000005337.
7
Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients.无住院日:危重症患者试验中一个注重实际且以患者为中心的结果
Am J Respir Crit Care Med. 2021 Oct 15;204(8):902-909. doi: 10.1164/rccm.202104-1063PP.
8
When should we start renal-replacement therapy in critically ill patients with acute kidney injury: do we finally have the answer?对于急性肾损伤的危重症患者,我们应该何时开始肾脏替代治疗:我们终于有答案了吗?
Crit Care. 2021 May 26;25(1):179. doi: 10.1186/s13054-021-03600-x.
9
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.比较两种延迟策略对严重急性肾损伤(AKIKI 2)患者开始肾脏替代治疗的效果:一项多中心、开放标签、随机、对照试验。
Lancet. 2021 Apr 3;397(10281):1293-1300. doi: 10.1016/S0140-6736(21)00350-0.
10
Recommendations on Acute Kidney Injury Biomarkers From the Acute Disease Quality Initiative Consensus Conference: A Consensus Statement.急性疾病质量倡议共识会议关于急性肾损伤生物标志物的建议:共识声明。
JAMA Netw Open. 2020 Oct 1;3(10):e2019209. doi: 10.1001/jamanetworkopen.2020.19209.